Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 129,001 shares at $243.37 ($31.6M) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Seasonal sale ($31.6M) by CEO & President — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.95 | 36,755 | $8.9M | 28.1% |
| 2 | $243.37 | 2,800 | $681K | 2.2% |
| 3 | $244.56 | 4,124 | $1.0M | 3.2% |
| 4 | $244.56 | 4,124 | $1.0M | 3.2% |
| 5 | $245.37 | 14,024 | $3.4M | 10.9% |
| 6 | $245.37 | 14,024 |
| $3.4M |
| 10.9% |
| 7 | $246.27 | 14,433 | $3.6M | 11.3% |
| 8 | $246.27 | 14,433 | $3.6M | 11.3% |
| 9 | $247.49 | 7,533 | $1.9M | 5.9% |
| 10 | $247.49 | 7,533 | $1.9M | 5.9% |
| 11 | $248.45 | 4,609 | $1.1M | 3.6% |
| 12 | $248.45 | 4,609 | $1.1M | 3.6% |
| Total | $244.68 avg | 129,001 | $31.6M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |